Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant ...

Advanced CGTs are expanding to larger patient populations, requiring strategic distribution approaches centered on patient needs. Effective channel strategies, broadening access, and reducing ...

The agency announced new draft guidance to simplify biosimilarity studies and reduce clinical testing that it has deemed ...

Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...

HHS Secretary Kennedy stated there is insufficient evidence to link Tylenol to autism, conflicting with the Texas lawsuit.

PE: What policy incentives are created by FDA's ANDA Prioritization Pilot? Botha: Right now, we’re seeing multiple efforts ...

The GCC is becoming a strategic anchor for global venture capital, with Riyadh emerging as a key fundraising hub. Sovereign ...

Thermo Fisher Scientific is set to acquire Clario Holdings after entering a $8.8 billion definitive agreement, which includes ...

GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...

Biologic age is determined by measuring how well the body’s cells and organs are functioning. This is different than ...

Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license ...

PE: What impact will FDA's ANDA Prioritization Pilot have on efficiency and competitiveness? Botha: Setting up new ...